NCT00168103 - Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions

Hereditary Angioedema

Interventions

BIOLOGICAL

C1 Esterase Inhibitor

Single application of C1-INH administered intravenously by slow injection or infusion at a recommended rate of 4mL/min.

BIOLOGICAL

Placebo

Single application of physiological saline solution equivalent to the volume calculated for subjects in the C1-INH 20 U/kg bw arm.

Trial Locations (36)

10461

Study Site, The Bronx

17033

Study Site, Hershey

30342

Study Site, Atlanta

33331

Study Site, Weston

45231

Study Site, Cincinnati

55411

Study Site, Plymouth

57702

Study Site, Rapid City

60612

Study Site, Chicago

68131

Study Site, Omaha

71130

Study Site, Shreveport

74133

Study Site, Tulsa

75230

Study Site, Dallas

83404

Study Site, Idaho Falls

91344

Study Site, Granada Hills

97401

Study Site, Eugene

98225

Study Site, Bellingham

02115

Study Site, Boston

Unknown

Study Site, Buenos Aires

Study Site, Westmead

Study Site, Plovdiv

Study Site, Sofia

Study Site, Edmonton

Study Site, Ottawa

Study Site, Brno

Study Site, Budapest

Study Site, Tel Litwinsky

Study Site, Skopje

Study Site, Grodzisk Mazowiecki

Study Site, Krakow

Study Site, Târgu Mureş

Study Site 1, Moscow

Study Site 2, Moscow

Study Site 3, Moscow

Study Site, Madrid

Study Site, Gothenburg

Study Site, London